Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23895999.
- Also identified by DOI 10.1016/j.biomaterials.2013.07.040.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A method for the sustained delivery of exenatide was proposed using nanoparticles (NPs) with a core/shell structure. The interactions between lipid bilayers and Pluronics were utilized to form various NPs using a layer-by-layer approach. Transmittance electron microscopy and dynamic light scattering were used to examine the morphology of the NPs. The in vitro release pattern was observed as a function of changes in the structure of the NPs, and the structural integrity of exenatide released was examined by SDS-PAGE analysis. Pharmacokinetics and antidiabetic effects were also observed with the structural change of NPs using in vivo animal models. In vitro-in vivo correlation was discussed in relation to manipulation of the NP structures.
Medical subject headings
- Diabetes Mellitus, Type 2
- Nanoparticles
- Peptides
- Venoms